INVEGA SUSTENNA is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Paliperidone Palmitate.
Product ID | 50458-561_86e7f21e-638b-11ea-8ce6-7c2bfc2ca371 |
NDC | 50458-561 |
Product Type | Human Prescription Drug |
Proprietary Name | INVEGA SUSTENNA |
Generic Name | Paliperidone Palmitate |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2009-07-31 |
Marketing Category | NDA / NDA |
Application Number | NDA022264 |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | PALIPERIDONE PALMITATE |
Active Ingredient Strength | 78 mg/.5mL |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-07-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022264 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-07-31 |
Ingredient | Strength |
---|---|
PALIPERIDONE PALMITATE | 78 mg/.5mL |
SPL SET ID: | 1af14e42-951d-414d-8564-5d5fce138554 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50458-560 | INVEGA SUSTENNA | paliperidone palmitate |
50458-561 | INVEGA SUSTENNA | paliperidone palmitate |
50458-562 | INVEGA SUSTENNA | paliperidone palmitate |
50458-563 | INVEGA SUSTENNA | paliperidone palmitate |
50458-564 | INVEGA SUSTENNA | paliperidone palmitate |
50458-606 | INVEGA TRINZA | paliperidone palmitate |
50458-607 | INVEGA TRINZA | paliperidone palmitate |
50458-608 | INVEGA TRINZA | paliperidone palmitate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVEGA SUSTENNA 77719232 4272521 Dead/Cancelled |
JOHNSON & JOHNSON 2009-04-22 |
INVEGA SUSTENNA 77408691 3709520 Live/Registered |
Johnson & Johnson 2008-02-28 |